Home › Insufficienza cardiaca › Florida › Orlando
Studi clinici su Insufficienza cardiaca a Orlando, FL
16 studi su Insufficienza cardiaca cercano partecipanti presso sedi a Orlando e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
In reclutamentoFase 3
- Flourish Research, Winter Park · a 5 mi di distanza
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
In reclutamentoFase 1
- Flourish Research, Winter Park · a 5 mi di distanza
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
In reclutamentoFase 3
- Flourish Research, Winter Park · a 5 mi di distanza
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
In reclutamentoFase 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · a 5 mi di distanza
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
In reclutamentoFase 3
- AdventHealth, Orlando
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
In reclutamentoFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · a 5 mi di distanza
- e altri 1
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
In reclutamentoFase 3
- Research Site, Orlando
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
In reclutamento
- Advent Health, Orlando
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
In reclutamento
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
In reclutamentoFase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · a 5 mi di distanza
- K2 Medical Research, Maitland · a 6 mi di distanza
Alleviant ALLAY-HF Study
In reclutamento
- Advent Health Orlando, Orlando
Assessment of CCM in HF With Higher Ejection Fraction
In reclutamento
- AdventHealth Orlando, Orlando
- Revival Clinical Research, Orlando
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
In reclutamentoFase 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · a 5 mi di distanza
CCM OPEN HF Registry
In reclutamentoStudio osservazionale
- AdventHealth Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
In reclutamentoFase 3
- AdventHealth, Orlando
Studi su Insufficienza cardiaca in altre città
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Altri studi a Orlando
- Cancro del polmone non a piccole cellule44 studi
- Obesità31 studi
- Cancro metastatico29 studi
- Sovrappeso27 studi
- Morbo di Alzheimer25 studi
- Diabete di tipo 224 studi
- Cancro (tutti i tipi)24 studi
- Cancro al seno23 studi
- Cancro ovarico22 studi
- Colite ulcerosa22 studi
- Cancro ai polmoni21 studi
- Cancro colorettale19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.